Earnings summaries and quarterly performance for U S PHYSICAL THERAPY INC /NV.
Executive leadership at U S PHYSICAL THERAPY INC /NV.
Board of directors at U S PHYSICAL THERAPY INC /NV.
Research analysts who have asked questions during U S PHYSICAL THERAPY INC /NV earnings calls.
Brian Tanquilut
Jefferies
4 questions for USPH
Also covers: ACHC, ADUS, AHCO +29 more
Joanna Gajuk
Bank of America
4 questions for USPH
Also covers: ACHC, ADUS, AGL +21 more
Michael Petusky
Barrington Research
4 questions for USPH
Also covers: ANIK, HAE, HSIC +8 more
Lawrence Solow
CJS Securities, Inc.
3 questions for USPH
Also covers: BTSG, CDRE, CLH +13 more
Benjamin Rossi
JPMorgan Chase & Co.
2 questions for USPH
Also covers: AMED, ARDT, AVAH +7 more
Constantine Davides
Citizens JMP
2 questions for USPH
Also covers: ADUS, AMN, CCRN +9 more
Jared Haase
William Blair & Company
2 questions for USPH
Also covers: ADUS, ALHC, DH +9 more
Jared Haas
William Blair & Company, L.L.C.
1 question for USPH
Jiten Sanghai
Corre Partners Management, LLC
1 question for USPH
Larry Solow
CJS Securities
1 question for USPH
Also covers: ARCB, BTSG, CDRE +14 more
Ryan Quinn
Corre Partners Management, LLC
1 question for USPH
Recent press releases and 8-K filings for USPH.
U.S. Physical Therapy, Inc. Updates Investor Presentation
USPH
Guidance Update
New Projects/Investments
M&A
- U.S. Physical Therapy, Inc. (USPH) updated its investor presentation on November 18, 2025, providing an overview of the company's operations and financial position for the Q3 2025 period.
- As of September 30, 2025, USPH operated 779 owned/managed outpatient physical and occupational therapy clinics across 44 states.
- For the trailing twelve months ended September 30, 2025, the company reported $759 million in revenues and $92 million in Adjusted EBITDA. Revenue growth was 18% year-over-year for the nine months ended September 30, 2025, compared to the same period in 2024.
- USPH added 99 clinics, including de-novo and acquisitions, between October 1, 2024, and September 30, 2025.
- The company reported $112.9 million in cash and $175 million available for borrowings under its revolving facility as of June 30, 2024.
Nov 18, 2025, 9:09 PM
U.S. Physical Therapy Inc. Reports Strong Q3 2025 Results and Reaffirms Full-Year Guidance
USPH
Earnings
Guidance Update
M&A
- U.S. Physical Therapy Inc. reported strong Q3 2025 financial results, with total patient visits increasing 18% year-over-year and physical therapy revenues growing 17.8% to $168.1 million. Adjusted EBITDA rose 13.2% to $23.9 million.
- The company reaffirmed its adjusted EBITDA guidance for full year 2025 to be in the range of $93 million to $97 million.
- Management anticipates a positive outlook for 2026, with the CMS final rule indicating a Medicare rate increase of 1.5% or better, reversing prior headwinds, and reinitiated opportunities from remote therapeutic monitoring.
- Acquisitions remain the primary capital allocation priority, especially in the Injury Prevention (IIP) segment due to better growth prospects, with 84 net PT facilities added in the last year.
- Operational efficiencies are improving, with PT salaries and related costs per visit decreasing $0.40 to $60.07 in Q3 2025, and initiatives like AI-driven documentation and front desk virtualization underway.
Nov 12, 2025, 9:09 PM
U.S. Physical Therapy, Inc. Announces Third Quarter 2025 Results
USPH
Earnings
Guidance Update
Dividends
- U.S. Physical Therapy, Inc. (USPH) reported net income attributable to shareholders of $13.1 million for the third quarter of 2025, an increase from $6.6 million in the prior year, with earnings per share of $0.48.
- Adjusted EBITDA for Q3 2025 increased 13.2% to $23.9 million compared to $21.1 million in Q3 2024.
- Total revenue from physical therapy operations grew 17.8% to $168.1 million in Q3 2025, primarily driven by clinic additions.
- Management reaffirmed its full-year 2025 Adjusted EBITDA guidance in the range of $93.0 million to $97.0 million.
- The Board of Directors declared a quarterly dividend of $0.45 per share payable on December 12, 2025.
Nov 6, 2025, 9:22 PM
USPH Reports Strong Q2 2025 Results, Raises Full-Year Guidance, and Authorizes Share Repurchase
USPH
Earnings
Guidance Update
Share Buyback
- USPH reported a strong second quarter for 2025, achieving record physical therapy volumes with 32.7 visits per clinic per day, up from 30.6 in Q2 last year, and an adjusted EBITDA of $26.9 million, an increase of $4.7 million compared to the prior year quarter.
- The company raised its full-year 2025 adjusted EBITDA guidance from a range of $88-$93 million to $93-$97 million, reflecting strong performance in the first half of the year.
- Both key segments demonstrated robust growth, with Injury Prevention (IIP) revenues increasing 22.6% (21.8% organically) and Physical Therapy (PT) revenues growing 17.3% to $168.3 million, largely driven by acquisitions.
- The Board of Directors authorized a share repurchase program of up to $25 million through December 31, 2026.
- For 2026, the company anticipates a positive Medicare rate increase of 1% to 1.75%, which is expected to contribute $2 million to $3 million to the top line and $1.5 million to $2.5 million to EBITDA, marking a shift from previous headwinds.
Nov 6, 2025, 3:30 PM
U.S. Physical Therapy Reports Strong Third Quarter 2025 Results
USPH
Earnings
Guidance Update
Dividends
- U.S. Physical Therapy reported Net Income attributable to USPH shareholders of $13.1 million for the 2025 Third Quarter, an increase from $6.6 million in the 2024 Third Quarter, with earnings per share rising to $0.48.
- Adjusted EBITDA for the 2025 Third Quarter increased 13.2% to $23.9 million , while total revenue from physical therapy operations grew 17.8% to $168.1 million , supported by an 18.0% increase in total patient visits.
- The company expanded its clinic count, reaching 779 total clinics as of September 30, 2025, after adding 18 and closing 7 clinics in the 2025 Third Quarter. Additionally, on July 31, 2025, the company acquired a 60% equity interest in a three-clinic practice.
- Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million and declared a quarterly dividend of $0.45 per share.
Nov 5, 2025, 10:00 PM
US Physical Therapy Inc. Provides Business Update and Financial Outlook
USPH
Guidance Update
New Projects/Investments
M&A
- U.S. Physical Therapy, Inc. (USPH) has faced Medicare reimbursement headwinds totaling $50 million in EBITDA cuts over five years, with $25 million in the current year, but these cuts are ending this year.
- Despite these challenges, the company achieved high double-digit growth (e.g., 18% last quarter) and updated its current year EBITDA guidance to between $93 million and $97 million.
- The company's industrial injury prevention business, started in February 2017, now generates over $100 million in revenue and over $20 million in EBITDA, growing 30% last quarter, with a gross margin approximately twice that of physical therapy.
- USPH operates a partner model (typically 70% ownership in nearly 800 facilities) and deploys capital through de novos (costing $170,000 to $200,000 each), strategic acquisitions (average buyback multiple of 7.25 times TTM EBITDA), and also has a share repurchase plan and pays a quarterly dividend of approximately $0.45.
Aug 26, 2025, 4:45 PM
Quarterly earnings call transcripts for U S PHYSICAL THERAPY INC /NV.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more